Can a med spa in Illinois offer compounded semaglutide or tirzepatide?
Facility · part of The Practice Perimeter
Short answer
Only if both compounding conditions are met — the commercial product is not reasonably available through normal distribution channels in time for that patient and the prescribing practitioner has requested compounding; cost is not a qualifying reason.
⚠️ Illinois puts two conditions on compounding a drug you could simply buy, and both must hold. “commercially available products may be compounded for dispensing to individual patients only if all of the following conditions are met: (i) the commercial product is not reasonably available from normal distribution channels in a timely manner to meet the patient’s needs and (ii) the prescribing practitioner has requested that the drug be compounded.” Availability is a SUPPLY-CHAIN test, not a price test — and the request must come from the prescriber.
225 ILCS 85/3 (“compounding”) · verified Sep 2, 2026 · regulatory monitoring, not legal advice
Related Illinois rules
Illinois ties sterile compounding for office use to a separate registration and license: “Sterile compounding for office use is prohibited unless the pharmacy is in full compliance with 21 USC 353b, including becoming registered as an outsourcing facility and licensed as a wholesale drug distributor pursuant to the Wholesale Drug Distribution Licensing Act [225 ILCS 120].” The same subsection adds that “a sterile compounded drug may be delivered to the prescribing practitioner's office for administration pursuant to a valid patient-specific prescription.”
68 Ill. Adm. Code § 1330.640(c) · verified Sep 19, 2026
And the definition itself ends where sale begins. “Compounding” means the preparation and mixing of components, excluding flavorings, “as the result of a prescriber’s prescription drug order or initiative based on the prescriber-patient-pharmacist relationship in the course of professional practice”, or incident to research, teaching or chemical analysis — “and not for sale or dispensing”. It includes preparing drugs “in anticipation of receiving prescription drug orders based on routine, regularly observed dispensing patterns”.
225 ILCS 85/3 (“compounding”) · verified Sep 2, 2026
How other states answer this
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District of Columbia
- Florida
- Georgia
- Hawaii
- Idaho
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
Related Illinois questions
- Is an exam required before a patient can be treated in Illinois?
- Can the pre-treatment exam be done by telehealth in Illinois?
- Who may perform the pre-treatment exam in Illinois?
- Must someone be on site while a patient is treated in Illinois?
Get Illinois changes as they publish
We scan the Illinois legislature and licensing boards daily, plus the FDA and the Federal Register. Free weekly Brief — what changed, in plain language, with the source.
Free · unsubscribe in one click · we never sell your address
← All Illinois rules and changes · MedSpaRadar is regulatory monitoring and reference: it summarizes public laws, regulations and agency actions and links each to its source. It is not legal, medical, or compliance advice, and using it creates no attorney-client relationship. A summary can lag its source or leave out detail, and monitoring itself can be interrupted — so an absence of alerts means nothing reached you, not that nothing happened. Read the cited source, check its effective date, and confirm any change to your operations or clinical practice with qualified health-law counsel and your medical director. Legislative data via LegiScan (CC BY 4.0).